Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMPROVE
PACTR202005615501026Phase 3Completed
- Sponsor
- Liverpool School of Tropical Medicine
- Start
- Sep 2017
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of dihydroartemisinin, piperaquine, azithromycin, sulfamethoxazole and trimethoprim in malaria, sexually transmitted disease (STD) and Genital infection (STI) (3 arms), sponsored by Liverpool School of Tropical Medicine. Started Sep 2017; status: completed.
02
Drugs
dihydroartemisininpiperaquineazithromycinsulfamethoxazoletrimethoprim
03
Conditions
malariasexually transmitted disease (STD)Genital infection (STI)
Beyond the preview
Go deeper on PACTR202005615501026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202005615501026.